Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Newsletter Article
|
Andrés Román's gesture that is an example of resilience and professionalism at NacionalCE Noticias Financieras, 2024CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
2 |
Material Type: Newsletter Article
|
Clinical Trial: Taiwan Registry of Hypertrophic Cardiomyopathy (THIC) Research SynopsisUS Fed News Service, Including US State News, 2024Copyright HT Digital Streams Limited Apr 24, 2024Digital Resources/Online E-Resources |
|
3 |
Material Type: Newsletter Article
|
Geisinger enrolls first patient in amyloid cardiomyopathy trialPR Newswire, 2024Copyright PR Newswire Association LLC May 10, 2024Digital Resources/Online E-Resources |
|
4 |
Material Type: Newsletter Article
|
Arrhythmogenesis in Dilated Cardiomyopathy: Role of Mechano-Electric CouplingMENA Report, 20242022 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. (Syndigate.info). ;EISSN: 2219-0112Digital Resources/Online E-Resources |
|
5 |
Material Type: Newsletter Article
|
Exercise, New Drug Class Recommended for Management of Hypertrophic CardiomyopathyTargeted News Service, 2024Targeted News ServiceDigital Resources/Online E-Resources |
|
6 |
Material Type: Newsletter Article
|
Mayo Clinic Q A: What is hypertrophic cardiomyopathy?News Bites - Private Companies, 2024Copyright News Bites Pty Ltd May 3, 2024Digital Resources/Online E-Resources |
|
7 |
Material Type: Newsletter Article
|
INTERNATIONAL PATENT: PROLAIO, INC. FILES APPLICATION FOR "SYSTEM AND METHOD OF TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY"US Fed News Service, Including US State News, 2024Copyright HT Digital Streams Limited May 1, 2024Digital Resources/Online E-Resources |
|
8 |
Material Type: Newsletter Article
|
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2024News Bites - Healthcare & Equipment, 2024Copyright News Bites Pty Ltd May 16, 2024Digital Resources/Online E-Resources |
|
9 |
Material Type: Newsletter Article
|
Press Release: Cytokinetics Announces Start of -2Dow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 8, 2024Digital Resources/Online E-Resources |
|
10 |
Material Type: Newsletter Article
|
Student died of cardiac complicationCE Noticias Financieras, 2024CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
11 |
Material Type: Newsletter Article
|
Clinical Trial: Efficacy and Safety of Thoracoscopic Morrow Surgery in the Treatment of Hypertrophic Obstructive CardiomyopathyUS Fed News Service, Including US State News, 2024Copyright HT Digital Streams Limited Apr 30, 2024Digital Resources/Online E-Resources |
|
12 |
Material Type: Newsletter Article
|
Cytokinetics Inc Submits Patent Application for Methods for Treating Hypertrophic CardiomyopathyGlobal IP News. Pharmaceutical Patent News, 2024Copyright© 2024, Globalipnews.comDigital Resources/Online E-Resources |
|
13 |
Material Type: Newsletter Article
|
University of Cincinnati issued patent titled "Methods of Treating Diabetic Cardiomyopathy by Inhibiting Glut1"News Bites - Private Companies, 2024Copyright News Bites Pty Ltd May 15, 2024Digital Resources/Online E-Resources |
|
14 |
Material Type: Newsletter Article
|
American Heart Association Inc: Exercise, New Drug Class Recommended for Management of Hypertrophic CardiomyopathyNews Bites - Private Companies, 2024Copyright News Bites Pty Ltd May 11, 2024Digital Resources/Online E-Resources |
|
15 |
Material Type: Newsletter Article
|
Mayo Clinic Arizona: Mayo Clinic Q A: What is hypertrophic cardiomyopathyNews Bites - Private Companies, 2024Copyright News Bites Pty Ltd May 9, 2024Digital Resources/Online E-Resources |
|
16 |
Material Type: Newsletter Article
|
INTERNATIONAL PATENT: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM FILES APPLICATION FOR "GENE THERAPY FOR LEMD2 CARDIOMYOPATHY"US Fed News Service, Including US State News, 2024Copyright HT Digital Streams Limited May 16, 2024Digital Resources/Online E-Resources |
|
17 |
Material Type: Newsletter Article
|
Cytokinetics Announces Start of CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic CardiomyopathyNews Bites - Healthcare & Equipment, 2024Copyright News Bites Pty Ltd May 9, 2024Digital Resources/Online E-Resources |
|
18 |
Material Type: Newsletter Article
|
INTERNATIONAL PATENT: OHIO STATE INNOVATION FOUNDATION, KRIGMAN, JUDITH FILES APPLICATION FOR "COMPOSITIONS AND METHODS FOR PREVENTING CARDIOMYOPATHY"US Fed News Service, Including US State News, 2024Copyright HT Digital Streams Limited May 1, 2024Digital Resources/Online E-Resources |
|
19 |
Material Type: Newsletter Article
|
Clinical Trial: Assessment of Cardiac Function, Microvascular Function and Cardiac Perfusion in Different Disease Stages of Hypertrophic CardiomyopathyUS Fed News Service, Including US State News, 2024Copyright HT Digital Streams Limited May 6, 2024Digital Resources/Online E-Resources |
|
20 |
Material Type: Newsletter Article
|
Press Release: Edgewise Therapeutics Doses First Patient in Phase 2 CIRRUS-HCM Trial of EDG-7500 in Obstructive Hypertrophic Cardiomyopathy (HCM)Dow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 6, 2024Digital Resources/Online E-Resources |